Merck Emend Part B Coverage Expanded And Simplified
Executive Summary
Medicare's broad coverage of Merck's Emend (aprepitant) under Part B will simplify reimbursement for the oral anti-emetic when Part D begins in 2006
You may also be interested in...
Medicare Rx Requires Pharmacies To Mind Their B’s And D’s
Pharmacists will have to keep careful track of prescriptions for some medicines that can be covered by Medicare Part B once the new Part D outpatient drug benefit begins in 2006
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials